- Perappadan, Bindu Shajan."India's first coronavirus infection confirmed in Kerala". The Hindu. 2020.
- "India most infected by Covid-19 among Asian countries, leaves Turkey behind". Hindustan Times. 2020.
- "IndiaFightsCorona COVID-19". MyGov.in. Govt of India. Retrieved. 2021.
- "India's COVID crisis 'beyond heartbreaking': WHO". www.aljazeera.com. 2021.
- Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. The lancet. 2020;395(10223):470-3.
- Gettleman, Jeffrey; Schultz, Kai. "Modi Orders 3-Week Total Lockdown for All 1.3 Billion Indians". The New York Times. 2020. ISSN. 0362-4331.
- Nerli RB, Sanikop AC, Sharma M, Ghagane SC. COVID-19 pandemic: A challenge to a child with cancer. Pediatr Blood Cancer. 2020;67(9):10-02.
- Nerli RB, Sampagar A, Sharma M, Ghagane SC, Deole S, Gupta P, Patil SD, Hiremath MB. Changing Paediatric Cancer Practice in COVID-19 Times. J Cancer Sci Ther. 2020;(12)7:1-5.
- Sharma M, Nerli RB, Ghagane SC. Urologic oncology during the COVID-19 pandemic. Journal of Emergency Practice and Trauma. 2022;8(1):55-9.
- Narain TA, Gautam G, Seth A, Panwar VK, Rawal S, Dhar P, Talwar HS, Singh A, Jaipuria J, Mittal A. Uro-oncology in times of COVID-19: The available evidence and recommendations in the Indian scenario. Indian Journal of Cancer. 2020;57(2):129-38.
- Ged Y, Markowski MC, Pierorazio PM. Advanced renal cell carcinoma and COVID-19—a personal perspective. Nature Reviews Urology. 2020;17(8):425-7.
- Bhanvadia S, Pal SK. Cytoreductive nephrectomy: questions remain after CARMENA. Nature Reviews Urology. 2018;15(9):530-2.
- Larcher A, Wallis CJ, Bex A, Blute ML, Ficarra V, Mejean A, Karam JA, Van Poppel H, Pal SK. Individualised indications for cytoreductive nephrectomy: which criteria define the optimal candidates?. European Urology Oncology. 2019;2(4):365-78.
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: a cancer journal for clinicians. 2018;68(1):7-30.
- Nerli R, Devaraju S, Hiremath MB, Guntaka AK, Patne P, Dixit N. Tumor doubling time of renal cell carcinoma measured by CT. Indian Journal of Urology. 2014;30(2):153-7.
- Pantuck AJ, Zisman A, Rauch MK, Belldegrun A. Incidental renal tumors. Urology. 2000;56(2):190-6.
- Motzer RJ, Russo P. Systemic therapy for renal cell carcinoma. The Journal of urology. 2000;163(2):408-17.
- Rini BI, Wilding G, Hudes G, Stadler WM, Kim S, Tarazi J, Rosbrook B, Trask PC, Wood L, Dutcher JP. Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma. Journal of Clinical Oncology. 2009;27(27):4462-8.
- Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The lancet oncology. 2020;21(3):335-7.
- Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D, Pouliot F, Alekseev B, Soulières D, Melichar B, Vynnychenko I. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. New England Journal of Medicine. 2019;380(12):1116-27.
- Motzer RJ, Tannir NM, McDermott DF, Arén Frontera O, Melichar B, Choueiri TK, Plimack ER, Barthélémy P, Porta C, George S, Powles T. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. New England Journal of Medicine. 2018;378(14):1277-90.
- Nerli RB, Shetty G, Jannu V, Aishwarya L. Safe Endourology Procedure Using a C-Arm Drape During Coronavirus 2019 Disease Times. J Endourol. 2020:887-8.
|
